These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34748113)

  • 1. Calcium channel blocker in patients with chronic kidney disease.
    Ohno S; Ishii A; Yanagita M; Yokoi H
    Clin Exp Nephrol; 2022 Mar; 26(3):207-215. PubMed ID: 34748113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.
    Moore KH; Clemmer JS
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F548-F557. PubMed ID: 34486399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
    Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M; Okada K; Soma M
    Curr Hypertens Rev; 2013 Aug; 9(3):202-9. PubMed ID: 24479749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
    Kanaoka T; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Fujikawa T; Tsurumi-Ikeya Y; Maeda A; Yanagi M; Toya Y; Umemura S
    Int J Mol Sci; 2013 Aug; 14(8):16866-81. PubMed ID: 23959116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
    PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
    Volpe M; Tocci G
    Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis.
    Li X; Yang MS
    PLoS One; 2014; 9(10):e109834. PubMed ID: 25330103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
    Locatelli F; Del Vecchio L; Andrulli S; Colzani S
    Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching to an L/N-type calcium channel blocker shows renoprotective effects in patients with chronic kidney disease: the Kyoto Cilnidipine Study.
    Hatta T; Takeda K; Shiotsu Y; Sugishita C; Adachi T; Kimura T; Sonomura K; Kusaba T; Kishimioto N; Narumiya H; Tanda S; Tamagaki K; Yamada K; Kameyama H; Kido H; Harada S; Bito Y; Moriguchi J; Morimoto S; Okigaki M; Itoh H; Mori Y; Nakata T; Maki K; Sasaki S; Sawada K; Matsubara H
    J Int Med Res; 2012; 40(4):1417-28. PubMed ID: 22971493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.
    Fici F; Seravalle G; Koylan N; Nalbantgil I; Cagla N; Korkut Y; Quarti-Trevano F; Makel W; Grassi G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):289-296. PubMed ID: 28497339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-type Ca channel blockade as a determinant of kidney protection.
    Hayashi K; Homma K; Wakino S; Tokuyama H; Sugano N; Saruta T; Itoh H
    Keio J Med; 2010; 59(3):84-95. PubMed ID: 20881449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers as initial therapeutic agents in hypertension: relationship to incident heart failure.
    Shields DL
    Biol Res Nurs; 2014 Jul; 16(3):266-77. PubMed ID: 23864228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.